Diabetes State Mandates and Insulin Copayment Caps


In 2018, 34.2 million Americans—or 10.5% of the population—had diabetes, with an additional 1.5 million Americans diagnosed every year. Beyond the sheer prevalence of the disease across the country, the costs of diagnosed diabetes have increased from $245 billion in 2012 to $327 billion in 2017, according to the American Diabetes Association.

Given the significance of diabetes in the U.S., many federal and state policymakers have pursued intervention strategies to improve access and coverage for diabetes-related services and treatments. This web page provides an overview of these strategies, including state health insurance mandates, federal mandates and caps on insulin copayments.